Minerva Capital

AI rebound ahead of earnings

Market Action

The S&P 500 closed at 7,690.73 (+0.41%), the Nasdaq Composite at 26,430.89 (+1.11%), the Dow at 51,966.03 (−0.07%), and the Russell 2000 at 2,728.30 (+0.25%). Tech and AI-linked names drove the rebound after last week’s sharp selloff (Nasdaq −4.5% for the week). The Philadelphia Semiconductor Index rose and snapped an eight-day losing streak. Breadth was mixed—most non-tech names lagged—as investors selectively reloaded into chips and AI infrastructure ahead of a heavy earnings stretch. The 10-year yield settled near 5.14%. Oil eased on reports of a U.S. waiver on certain Russia sanctions and tariffs (amid ongoing Hormuz tensions), though levels remain elevated.

Story of the Day: Selective AI Dip-Buy Ahead of Earnings

Nothing fundamental flipped over the weekend, but sentiment had turned extremely negative after last week’s rate and financing pressure (especially around neocloud debt). Dip buyers stepped in on chips, memory, and AI infrastructure. The real test is this week’s earnings from AI spenders and enablers: SpaceX (Tuesday), Meta and Tesla (Wednesday), Netflix, and others. A clean delivery of growth and capex discipline can extend the bounce; disappointment reopens the debate on valuations and balance-sheet quality at elevated yields.

Key Catalysts and Movers

- $Amazon(AMZN.US) : Morgan Stanley named it a Top Pick and raised its price target to $350 from $335 (Overweight). The firm lifted AWS growth forecasts to 47% in 2027 and 42% in 2028 (from 41%/37%), citing expected Nvidia GPU deployments of ~2 million units, plus higher incremental margins supporting ~$16.50 of 2028 EPS. Other catalysts include Bedrock visibility, agentic shopping, and robotics. Shares rose ~5% to the mid-$260s (highest close since late August). Earnings October 29.

- $Intel(INTC.US) : JPMorgan upgraded to Neutral from Underweight (ending a bearish call held since late 2022) with an unchanged $85 target. The firm cited improved execution under CEO Lip-Bu Tan (yields, advanced packaging, core PC/data-center competitiveness) and support from agentic AI workloads that are CPU-intensive. The stock had pulled back ~36% from its June peak, bringing risk/reward closer to balance; JPM’s 2028 EPS estimates sit ~15% above consensus. Shares rose ~3% into the low-$90s. Share losses and a still-tiny external foundry business remain open issues.

- $Coreweave(CRWV.US): Goldman Sachs upgraded to Buy from Neutral while cutting its price target to $106 from $139 (still implying substantial upside from Friday’s close). The firm views financing concerns as overstated—asset-backed debt is manageable, DDTLs remain available, and the ~$104B backlog provides visibility. The stock ended essentially flat near $61 after an early bounce; it had fallen ~25% last week as bond yields spiked toward 15% on its debt load. Peers $Nebius(NBIS.US) and $IREN(IREN.US) also recovered. The debate is now whether credit spreads stabilize or whether the higher cost of capital permanently compresses the unlevered-IRR/WACC spread.

- Memory/storage complex: $Sandisk(SNDK.US), $Western Digital(WDC.US), $Micron Tech(MU.US) and related names posted strong gains (several in the mid-to-high single digits) as last week’s sentiment damage reversed. The move is primarily a bounce in the AI-hardware tape rather than fresh fundamental data.

- $Cleveland Cliffs(CLF.US): Reported strongest quarter in three years—adjusted EPS $0.28 (beat), revenue $5.61B, adjusted EBITDA $612M (well above prior guidance). Guides Q4 adjusted EBITDA ~$715M on higher pricing. Shares surged 16%+. Tariff and pricing backdrop remains supportive.

- $Silence Therapeutics(SLN.US): +125% after Merck KGaA agreed to acquire the company for $20 cash per ADS (~130% premium to Friday’s close; ~$1.3B equity / $1.1B enterprise value). Adds a Phase 3-ready siRNA asset (divesiran for polycythemia vera). Expected close Q1 2027; remaining spread reflects time and completion risk. Analysts quickly moved to Hold/Neutral at the deal price.

Macro and Cross-Currents

Europe underperformed on French political unrest and weekend protests. Oil is still historically high but pulled back on the Russia waiver headlines. Elevated long-end yields continue to pressure rate-sensitive sectors (real estate, housing) while the AI tape can absorb them on growth optimism. Monday also marked the 39th anniversary of Black Monday 1987—more calendar note than market signal.

What Matters Next

The earnings calendar is the clear catalyst: guidance and commentary on AI spend, margins, and financing from $Meta Platforms(META.US), $Tesla(TSLA.US), $Netflix(NFLX.US), $SpaceX(SPCX.US) and the broader Mag7 complex will decide whether today’s bounce sticks. For storage, watch whether pricing and allocation tightness hold. For neoclouds, credit spreads and the ability to refinance at acceptable spreads remain the swing factor. High yields keep the bar high for pure multiple expansion.

FinTwit / Narrative Pulse

The dominant tape narrative is “oversold bounce into earnings.” Goldman’s and JPM’s defenses of $Coreweave(CRWV.US) and $Intel(INTC.US) were widely circulated. Selective dip-buying in AI infrastructure is the story, not a broad risk-on regime. Narratives around neocloud debt sustainability versus backlog durability continue to trade in real time.

NFA / DYOR. This is independent market commentary based on public information for informational purposes only and is not investment advice, a recommendation, or a solicitation to buy or sell any security. Markets, facts, and circumstances change rapidly.

AI rebound, biotech wins, earnings week

Futures point to a rebound after last week’s sharp tech/AI selloff (Nasdaq Composite -4.5% for the week, largest since late June; S&P -2%). AI-linked names are leading the bounce ($NVIDIA(NVDA.US) +1–2%, $Broadcom(AVGO.US) +2%+, semis and memory groups higher), helped by lower oil and modestly easier Treasury yields.

The 10-year is around 5.08–5.09%. Brent is down ~1.8–2% to the mid-$107s after President Trump waived key provisions of the Graham Act Russia sanctions package (signed into law last month and set to take effect this week), citing national interest and efforts to ease energy prices ahead of midterms. Zelensky has criticized the move.

Risks remain: another tanker mine hit reported in the Strait of Hormuz, with shipping/insurance costs still elevated. Fed Chair Kevin Warsh offered no rate signal last week; markets price a high probability (~72–85%) of a hold at the Oct 27–28 meeting after September’s hike, with a December hike still possible. Higher-for-longer rates remain a overhang for AI infrastructure financing. Today’s main data point is the NAHB Housing Market Index at 10 a.m. ET (prior 32).

AI Infrastructure & Semis: Dip-Buying After Financing Scare

Last week’s pressure on AI capex sustainability, data-center debt, and higher rates is reversing in premarket. Neoclouds are notable: $Coreweave(CRWV.US) +6%+ after Goldman Sachs upgraded it to Buy from Neutral (PT cut to $106 from $139, still implying substantial upside). GS cites tighter supply supporting ARR per MW and unlevered IRR, differentiation versus peers, and overestimation of capital costs by the market after the stock’s recent drop (~43% from mid-August, -24% in five days).

$Nebius(NBIS.US) and $IREN(IREN.US) are also higher in sympathy. Memory names ($Micron Tech(MU.US), $Sandisk(SNDK.US) and related) are rebounding as part of the broader semi complex. FinTwit chatter frames this as selective buy-the-dip in the hardest-hit AI infra names, with the key test being follow-through and whether earnings this week provide monetization evidence rather than just more spending commitments. One note of caution circulating is that financing spreads had widened and nothing fundamental changed overnight.

$Intel(INTC.US) is up ~4% after JPMorgan upgraded it to Neutral from Underweight (PT unchanged at $85). The firm sees more balanced risk/reward after a ~36% drop from the June peak. Since Lip-Bu Tan’s appointment as CEO, execution has improved in core client/data-center compute and next-gen manufacturing (yields, foundry compatibility, advanced packaging). JPMorgan also points to agentic AI workloads (CPU-intensive) and tight leading-edge silicon supply as potential drivers of positive EPS revisions into 2027; its 2028 EPS is ~15% above consensus. This is a classic “valuation reset + operational progress” catalyst after prior underperformance versus the group.

Biotech Binary Outcomes

$Disc Medicine(IRON.US) (Disc Medicine) is surging 40%+ (and higher in some prints) after announcing that its Phase 3 APOLLO trial of bitopertin in erythropoietic protoporphyria (EPP, including XLP) met all primary and secondary endpoints. Co-primaries: 41.4% reduction in whole-blood metal-free PPIX vs placebo (p<0.0001) and +12.2 hours average monthly time in light without pain in month 6 (p=0.0010). Secondary endpoints on phototoxic reactions and cumulative light tolerance were also hit. The drug was generally well-tolerated (dizziness most common TEAE). Company plans to resubmit NDA by year-end 2026 with a potential mid-2027 FDA decision. This directly addresses the prior Complete Response Letter. Webcast this morning at 8 a.m. ET. Rare-disease positive readout with clear regulatory path is a classic high-conviction catalyst.

$EyePoint(EYPT.US) (EyePoint) is collapsing ~80%+ after the second Phase 3 LUCIA trial of Duravyu in wet AMD failed the primary non-inferiority endpoint versus Regeneron’s Eylea (vision improved but not enough to meet the bar). Company is ending the wet AMD pivotal trials early, cutting ~53% of its workforce (annualized savings ~$30M), and shifting focus to diabetic macular edema (Phase 3 data expected Q4 2027). Cash was ~$118M as of Sept 30. This is the second miss (prior failure in August triggered a large drop); capital preservation and pipeline pivot are the near-term story, with high residual binary risk.

Software & Observability

$Datadog(DDOG.US) is up ~3.6% after Bernstein SocGen upgraded it to Outperform from Market Perform and raised the PT sharply to $350 from $237. The firm is more constructive on AI demand strength after previously flagging concerns around a large “Born in AI” customer contract downsizing and traditional customer softness. AI observability remains a structural tailwind narrative on FinTwit for infrastructure software that owns critical telemetry and context layers.

Earnings Calendar This Week (Catalyst Heavy)

Monday is relatively light (already includes $Cleveland Cliffs(CLF.US), which reported Q3 adjusted EPS $0.28 beating ~$0.24, revenue $5.61B, adjusted EBITDA $612M above the $575M guide, and a constructive Q4/2027 outlook; stock +13% pre). The real tests arrive mid-week:

- Tuesday: $Netflix(NFLX.US), $SpaceX(SPCX.US) (SpaceX), $General Motors(GM.US), $GE Aerospace(GE.US), $RTX(RTX.US), others.

- Wednesday: $Meta Platforms(META.US), $Tesla(TSLA.US), $IBM(IBM.US), $Lam Research(LRCX.US), $Texas Instruments(TXN.US) and more.

- Thursday/Friday: $Procter & Gamble(PG.US), $Lockheed Martin(LMT.US), $Western Digital(WDC.US), $American Express(AXP.US), etc.

After last week’s AI financing and rate-driven selloff, guidance and commentary on AI spend ROI, capex intensity, and demand will be closely watched. Options implied moves on several names are elevated. A clean beat-and-raise cycle from the larger names would reinforce the premarket rebound; weak monetization language could reverse it quickly.

Other Notes

- Oil remains geopolitically sensitive despite the Russia waiver; Hormuz incidents continue to create noise without fully clearing.

- Broader semi lead-time and pricing data from prior weeks (passives, power, analog) had been supportive of the upcycle; the rebound today is consistent with that backdrop but rate sensitivity is the new variable.

- Pre-market volume leaders include several AI/semi names plus the biotech extremes noted above. Selective positioning is the prevailing FinTwit posture: favor names with specific catalysts (upgrades, data, earnings) over pure beta into the print week.

NFA / DYOR. This is not financial advice. Markets move on new information; do your own research and manage risk accordingly.

Warsh dovish, CRWV drops, banks mixed

October 16, 2026

No single dominant thread this morning — futures mixed after Fed Chair Kevin Warsh’s IMF remarks in Bangkok failed to signal urgency for an October rate hike despite this week’s hotter inflation readings. Markets pared hike odds (roughly 27% pre-speech to ~15% or lower), the dollar eased, and equities stabilized after AI-related volatility.

Oil remains elevated (~$98 WTI / ~$105 Brent) amid geopolitical noise. AI debt/financing concerns and memory pricing linger as the key overlay for growth names. Lay it out: prioritize the macro read-through, then AI leverage risks, then today’s bank prints and single-stock catalysts.

### Macro / Fed

★ MOST ACTIONABLE · ▲ POSITIVE (near-term risk asset support)

Warsh, speaking with IMF MD Georgieva, reiterated the Fed’s commitment to price stability after the September hike but explicitly declined to prejudge the Oct 27–28 meeting or remaining 2026 decisions. “I don’t prejudge meetings.” Markets interpreted the lack of hawkish guidance as dovish-leaning, supporting a short-term bounce in equities and lower rate-hike pricing. Expert take: Some strategists note the absence of forward guidance is consistent with Warsh’s style; inflation and energy still constrain the path higher. Broader narrative on FinTwit: Higher-for-longer rates are pressuring leveraged AI infrastructure more than the broader tape.

### AI Infrastructure & Memory

★ MOST ACTIONABLE · ▼ NEGATIVE · $Coreweave(CRWV.US) $Micron Tech(MU.US) $Sandisk(SNDK.US) $Western Digital(WDC.US) $SK Hynix(SKHY.US)

$Coreweave(CRWV.US) remains the poster child for AI financing stress — down ~4–5% premarket and tracking a ~20% weekly drop. Debt/yield concerns (bonds in distressed territory, CDS elevated, ~$50B debt load) dominate. Jensen Huang’s supportive comments and Deutsche Bank’s “buying opportunity” framing helped a Thursday bounce, but it faded. Cantor Fitzgerald called the selloff “a lot of fearmongering,” reiterated Overweight with a $176 PT (~150% upside), and highlighted sold-out 2027 capacity plus Nvidia backstop.

Memory complex ($Micron Tech(MU.US) , $Sandisk(SNDK.US), $Western Digital(WDC.US), $SK Hynix(SKHY.US)) softer on the same rate/AI-spend anxiety and pricing worries. Narrative on FinTwit: Circular financing and higher borrowing costs are hitting the most leveraged neocloud and storage names hardest — rotation out of pure AI leverage into broader/defensive sectors continues.

### $Tesla(TSLA.US) Roadster Catalyst

▲ POSITIVE (narrative/hype)

$Tesla(TSLA.US) up ~3%+ premarket after the long-delayed Roadster unveil at a SpaceX site. Demonstrations included thruster-enabled stunts (upside-down driving, barrel rolls, short flights), claims of sub-1-second 0-60 and >230 mph, with production targeted for 2028. Expert commentary: Classic Musk narrative event — strong social/FinTwit engagement, but history of delays means limited near-term fundamental impact on core auto/energy businesses. More sentiment catalyst than earnings driver.

### Earnings (Banks BMO Today)

★ MOST ACTIONABLE · Mixed

- $Travellers(TRV.US): Strong beat. Core EPS $9.18 vs ~$7.4 consensus, driven by favorable prior-year reserve development and higher net investment income. Combined ratio 86.8%. Stock still down premarket (~-4%) — classic “sell the news” or macro overlay.

- $Citizens Financial(CFG.US): EPS $1.41 beat (~$1.39), but revenue $2.32B miss. NII solid, NIM 3.19%. Dividend raised 13% to $0.52 and buyback capacity increased. Shares down ~5% premarket on the revenue miss.

- $Truist Financial(TFC.US): Adjusted EPS $1.16 (around consensus), impacted by strategic loan sale and securities repositioning. Solid adjusted ROTCE.

- $M&T Bank(MTB.US): EPS $5.04 beat (~$4.95) on lower-than-expected provisions; loans up.

- $Regions Financial(RF.US): Adjusted EPS $0.73 beat ($0.66). Solid NIM and credit metrics.

- $Alcoa(AA.US) (prior AMC): Adj EPS $1.82 beat, sales miss. Stock modestly higher on operational progress, cash generation, and AliGroup financing update.

### Analyst Actions

▲ POSITIVE examples

- $Fox(FOXA.US): BofA double upgrade Underperform → Buy, PT raised to $85.

- $Zeta Global(ZETA.US): Goldman Neutral → Buy.

- $Greif(GEF.US): Raymond James Market Perform → Outperform.

- $Barrick Mining(B.US)rinker(EAT.US): Raymond James to Strong Buy.

Mixed elsewhere (e.g., some $Semtech(SMTC.US) PT cuts alongside upgrades; $Barrick Mining(B.US) downgrade).

### Pre-Market Movers on Volume

- $Fractyl Health(GUTS.US): Down ~45–48% despite REMAIN-1 6-month data meeting the co-primary endpoint (80% GLP-1 weight-loss retention vs 67% sham, p=0.0023; dose-dependent effect with more complete ablation). Favorable safety. Classic sell-the-news — expectations were high for a cleaner commercial/longer-term profile. Expert view: Efficacy and safety support the De Novo path, but the market is punishing for not exceeding the bar.

- $SITE Centers(SITC.US): Up ~18% on $3 special dividend (funded by JV sale) plus voluntary NYSE delisting plan (post-div market-cap risk). Due-bill period applies; post-delist liquidity likely thinner.

- Speculative small-cap gaps continue in names like $Alaunos Therapeutics(TCRT.US), $Jaguar Health(JAGX.US), $House of Doge(HODO.US), $Exascale Labs(XLAB.US) on thin news/volume.

**NFA / DYOR** — This is for informational and discussion purposes only, not financial advice. Do your own research. Catalysts move fast, especially on FinTwit and pre-market; past performance and narratives do not guarantee results. Shared for X discussion.

CRWV rebound, TSM earnings, PPI reaction

October 15, 2026

The tape rotated hard out of the AI complex into the rest of the market. The S&P 500 closed +0.33% at 7,744, the Dow jumped +1.08% to 52,178, the Nasdaq managed only +0.08% to 26,713, and the Russell 2000 rose ~1.3–1.4%. Breadth was solid (roughly 7 of 10 S&P names higher) after an early dip. The 10-year yield fell ~9–10 bp to ~5.08–5.10% even as September PPI printed hot at +1.3% m/m and +6.3% y/y (well above consensus). Stocks absorbed the inflation print via lower yields and a defensive/broad rotation; tech (especially chips and AI infrastructure) lagged after the prior session’s funding scare.

AI Infrastructure Funding Scare Meets Huang’s Pushback

The dominant catalyst remained the re-pricing of AI financing risk, centered on $Coreweave(CRWV.US). Bond yields on its notes spiked toward 15% earlier in the week, CDS widened sharply, and the stock dropped ~15% Wednesday amid Gartner commentary on neocloud longevity and broader worries about leveraged data-center build-outs. Elon Musk’s “yikes” reply to a bond-yield chart added to the noise.

Today $Coreweave(CRWV.US) rebounded ~6% (closing near $69.70) after Nvidia CEO Jensen Huang, speaking in Stockholm, said CoreWeave’s strength is “improving every day,” its cost of capital is decreasing, and he does not see a need for Nvidia to provide a bailout. Nvidia already holds ~10% of the company and has a multi-year capacity purchase commitment. The comments helped stabilize parts of the AI complex (some neocloud and related names pared losses), but credit-market stress had not fully disappeared and the broader semiconductor bid stayed selective. For swing traders, this is a classic sentiment-reset catalyst: the fundamental backlog ($100B+ contracted) and Huang’s endorsement matter more than the overnight bond panic, but elevated funding costs remain a live risk if utilization or pricing disappoints. Watch whether the rebound holds into the next earnings window and whether peers ($Oracle(ORCL.US), $Nebius(NBIS.US), etc.) follow.

$Taiwan Semiconductor(TSM.US) Crushes Numbers, Stock Still Soft

Taiwan Semiconductor reported another record quarter: profit up ~69% y/y, revenue well above guidance, and Q4 revenue outlook of $52.3–54.3B (strong sequential growth). Management reiterated extremely robust demand for leading-edge AI and HPC chips. The U.S.-listed shares still finished lower as the broader AI sell-off overshadowed the beat. The print reinforces the “picks-and-shovels” case for the foundry and its key customers ($NVIDIA(NVDA.US), $AMD(AMD.US), $Broadcom(AVGO.US)), but the market is currently more focused on the financing side of the build-out than on end-demand confirmation. Near-term, the reaction shows how quickly good fundamental news can be discounted when the narrative is about capital intensity and credit.

Other Catalysts and Earnings

$Ericsson(ERIC.US) rose after a solid Q3 beat: organic sales +7%, adjusted EBITA ahead of consensus, Networks strength and cost discipline. Management noted higher component costs will pressure margins next year, but the print was clean enough to drive a clear positive reaction.

Healthcare led sectors (XLV ~+1.8–2%), helped by rotation into defensives and specific catalysts such as $Moderna(MRNA.US) (+4–5% after a Goldman target raise tied to Phase 3 melanoma data optimism). $Eli Lilly(LLY.US), $Unitedhealth(UNH.US) and other large-caps participated.

Analyst activity included upgrades on names such as $Bank of America(BAC.US) (to Outperform) and $Crocs(CROX.US), plus various initiations/resumptions, but nothing that redefined the tape the way the AI credit story and $Taiwan Semiconductor(TSM.US) print did.

Energy lagged (~-1.5%) despite some oil firmness; real estate and rate-sensitive areas benefited from the yield decline.

Healthcare, materials, consumer discretionary and financials led; technology and energy lagged. Equal-weight participation was healthier than the Nasdaq close implies—classic rotation rather than a broad risk-off day.

Notable Movers

Gainers: $Coreweave(CRWV.US) (rebound on Huang), $Ericsson(ERIC.US) (earnings), healthcare names, some Brazil-linked or other idiosyncratic moves from prior sessions continuing in pockets.

Decliners: Select AI/chip and infrastructure names that remained under pressure from the funding narrative; certain industrial or rate-sensitive names that did not fully participate in the Dow strength.

What Matters Next

Whether the $Coreweave(CRWV.US) rebound and Huang’s comments stabilize the AI financing narrative or if bond/CDS stress re-emerges (key for $NVIDIA(NVDA.US) and the broader complex).

More earnings (banks and others still reporting) and whether estimate revisions follow the $Taiwan Semiconductor(TSM.US) beat or stay muted by capital-cost worries.

Bond-market behavior with the 10-year near 5.1% after the hot PPI; a sustained yield drop would support the rotation, while a re-test of recent highs would pressure rate-sensitive and leveraged names.

FinTwit narratives around “AI overbuild vs. real demand” remain live—watch for continued debate on utilization, power, and funding costs versus pure semiconductor strength.

NFA / DYOR. This is market commentary based on public information and is not investment advice.

AI Selloff Deepens on CPI

October 15, 2026

AI Selloff Deepens Into a Second Day as Hot CPI Lifts Hike Odds; $Taiwan Semiconductor(TSM.US) Beats but Can't Lift the Tape

There’s no clean single thread this morning, but the overlapping pressures are clear. Yesterday’s hotter-than-expected September CPI (headline 3.7%, core 2.6% vs. 2.5% expected) put an October Fed hike back on the table and triggered a sharp AI/semis selloff.

Overnight the pressure continued: Nasdaq 100 futures are down roughly 1.1%, S&P 500 futures modestly lower, while Dow futures are slightly green as investors rotate toward safer assets and yields pull back. Strong prints from $Taiwan Semiconductor(TSM.US) and solid (if decelerating) numbers from Anthropic are not yet enough to reverse the tape.

The market is now stress-testing AI capex returns, financing costs, and rate sensitivity at the same time.

Macro: Hot CPI Keeps October Hike Odds Elevated

September CPI came in hotter, driven in part by gasoline and broader pressures. Market pricing for an October hike (meeting Oct 27-28) jumped toward 50/50 before Fed officials (including comments from Bowman and Daly) tempered expectations somewhat. Swaps still reflect meaningful hike odds versus the more dovish lean after softer labor data earlier.

Swing implication: Rate-sensitive high-beta tech remains vulnerable on multi-day follow-through. Defensives and selective value have been relative winners.

AI Infrastructure Debt Concerns: $Coreweave(CRWV.US) Continues Lower

$Coreweave(CRWV.US) is down another ~6% pre-market after plunging ~15% yesterday. Bond yields on certain unsecured notes have pushed toward 15% (with some notes trading below 80 cents), and credit default swap levels have spiked. CEO Mike Intrator has pushed back, citing a ~$104B revenue backlog and recent new commitments, arguing the market is acting “irrationally.” Interest expense has already risen sharply, and the company is guiding substantial ongoing capex.

Anthropic told prospective investors Q3 revenue reached $16.8B (up ~45% sequentially from ~$11.6B in Q2, after a much stronger sequential jump earlier). It also claimed adjusted profitability and cash-flow positivity. The absolute numbers are large, but the deceleration versus prior quarters has added to ROI and financing skepticism around the broader AI buildout.

FinTwit narrative flag: The “AI debt / private credit bubble” conversation is loud. Strong demand is being separated from sustainable capital returns. Names with heavy external financing and limited free-cash-flow buffers are under the most pressure.

Swing view: $Coreweave(CRWV.US) and related neoclouds remain high-volatility catalysts. Further bond-market stress can drive multi-day equity moves independent of operating updates.

Memory & Semis Under Continued Pressure

Memory and AI-related semis are extending losses: $Micron Tech(MU.US), $Sandisk(SNDK.US), $SK Hynix(SKHY.US), $Western Digital(WDC.US), $Seagate Tech(STX.US), and others are down several percent pre-market. South Korea’s Kospi had a sharp session (with Samsung and SK Hynix hit hard), and the broader SOX has been under pressure. The combination of higher rate expectations and questions about AI infrastructure financing is outweighing individual positive data points for now.

Expert takeaway: Memory remains supply-constrained on many AI workloads, but the near-term tape is pricing duration and financing risk more than the medium-term shortage narrative.

$Taiwan Semiconductor(TSM.US): Clean Beat and Raise, Still Not Rewarding the Tape

$Taiwan Semiconductor(TSM.US) reported Q3 revenue of $46.72B (up ~41% YoY, ahead of expectations) and diluted EPS of $4.60 per ADR. Gross margin was 66.4% and operating margin 58.7%. Advanced nodes (7nm and below) accounted for a high share of wafer revenue, with 2nm already contributing.

Q4 guidance of $52.3–54.3B is above consensus, and the company has pointed to continued strong demand with “no ceiling” language on some AI-related demand. At the same time, management struck a more prudent tone heading into 2027 amid macro uncertainties.

The ADR is not seeing a clean positive reaction in early trading. Options had priced a meaningful move; the print itself was solid, but the broader risk-off in AI hardware is dominating.

Swing implication: High-quality AI infrastructure with visible demand and margins can still be held or bought on weakness if the financing narrative stabilizes, but near-term drawdown risk remains elevated while the credit and rate backdrop is unsettled.

$FMC(FMC.US): Severe Guidance Cut and Commercial Charges

$FMC(FMC.US) is the standout pre-market loser, down ~45%. The company slashed Q3 expectations dramatically, now guiding revenue of only $65–125M and Adjusted EBITDA of roughly negative $510–565M. This includes $625–675M in charges tied to commercial actions (price reductions on inventory held by channel partners in key markets and a restructuring of the U.S. pricing model). Management cited weaker-than-expected demand, elevated higher-priced inventory at distributors, and pressure from generic competition.

Swing view: This is a classic inventory/channel reset catalyst. Recovery will likely take multiple quarters; near-term follow-through risk is high.

$Penske Auto(PAG.US): Take-Private Deal Announced

$Penske Auto(PAG.US) is up roughly 8% after agreeing to be taken private by Penske Corp and Mitsui at $212 per share (enterprise value ~$16.3B). The price represents a modest premium to recent levels. Closing is targeted for Q1 2027, subject to approvals.

Swing note: Deal-related moves of this type often have limited further upside once the terms are known, though financing and regulatory path remain watch items.

Analyst Actions and Other Earnings

$Walmart(WMT.US): Deutsche Bank upgraded to Buy from Hold, raising the price target to $136 from $113. Thesis centers on a more constructive 2027 outlook and inflation supporting the value proposition. Shares are up modestly pre-market.

$Bank of America(BAC.US) and others saw upgrades (Baird to Outperform on $Bank of America(BAC.US)).

Bank earnings are in focus today (including $BNY, $PNC Financial Services(PNC.US), $Charles Schwab(SCHW.US), $US Bancorp(USB.US)). Early results have been mixed-to-solid on the fee and NII side.

$Ericsson(ERIC.US) is up on a stronger-than-expected Q3 print.

$Rocket Lab(RKLB.US) is lower after delaying the Neutron rocket debut into 2027.

Bottom Line for Swing Traders

The dominant near-term drivers are the interaction between sticky inflation/Fed hike odds and questions about AI capex returns and financing costs. $Taiwan Semiconductor(TSM.US)’s beat confirms demand is still strong at the foundry level, but it has not been enough to reverse the broader AI hardware selloff. Memory and neocloud names with heavy leverage are the highest-beta expressions of the current narrative. Watch PPI/retail sales for the macro follow-through and any further credit-market signals around AI infrastructure.

Defensive rotation and selective single-name catalysts (deal announcements, upgrades, guidance cuts) are providing relative opportunities while the high-beta AI complex digests the latest data.

NFA / DYOR — This is not financial advice. Markets are volatile; do your own research and manage risk accordingly.

Minerva Morning Update

October 13, 2026

Futures are mixed heading into a heavy bank-earnings morning and the continued memory/AI chip selloff. Dow futures are modestly green (helped by $Unitedhealth(UNH.US)), S&P roughly flat to slightly red, and Nasdaq futures down ~0.5–0.6% as the CXMT overhang and related AI-sentiment caution keep pressure on semiconductors. Oil is retreating ~2% (WTI ~$92, Brent ~$105), which is offering some relief to the inflation impulse and yields (10-year easing toward ~5.19%). CPI is tomorrow; positioning remains cautious.

Memory / Semis: CXMT 4F² Claims Drive Another Day of Selling — Narrative Risk on Commodity DRAM Scarcity

China’s CXMT claims progress on a denser 4F² DRAM cell architecture (vertical surrounding-gate design aimed at cutting cell area ~33% and boosting density) and plans to launch a server DDR5 RDIMM by year-end. Samsung and SK Hynix have this on longer roadmaps (Samsung mass production targeted later, around 2028 in some reports). The announcement has hit hard: Samsung and SK Hynix down sharply (KOSPI under heavy pressure, often 5–6%+), with $Micron Tech(MU.US), $Sandisk(SNDK.US) and broader $SMH names soft in premarket/overnight trading after Monday’s declines.

Expert / market read: The move is primarily on commodity/server DRAM pricing-power fears rather than immediate HBM displacement. HBM for AI remains tight/sold-out through 2026 in prior commentary, and CXMT still faces yield, volume, customer-qualification, and tool-restriction hurdles under U.S. sanctions. Many view the reaction as an overreaction short-term (scarcity premium getting marked down on an unproven timeline), but it is a live narrative challenge to the “memory shortage persists deep into 2028 / peak pricing / structural LTA” thesis that has powered the group. FinTwit is flagging the competition overhang as the tape driver overnight and into the open, with some dip-buy interest in $Micron Tech(MU.US) around recent levels if selling eases, while others treat it as continued de-risking in the AI complex.

Broadcom’s Hock Tan comments (comparing some AI investors to “casino gamblers” with extreme expectations and questioning enterprise token ROI / lab economics) have added to the cautious sentiment overlay, even as underlying AI infrastructure demand commentary remains strong. Watch whether the bank-earnings bid or oil relief spills over, or if memory stays offered into CPI.

Bank Earnings Kickoff:

Mixed Prints — $Goldman Sachs(GS.US) Strong, $Unitedhealth(UNH.US) Beat-and-Raise, $JPMorgan Chase(JPM.US) Softer

$Goldman Sachs(GS.US): Strong beat. EPS $17.01 (well above ~$13 consensus), net revenues $18.7B (+23% YoY). Equities revenue +72% on volatility; IB fees +21% with record advisory. Stock up solidly premarket. CEO Solomon noted a complicated environment but solid client activity and positioning.

$Unitedhealth(UNH.US): Clear beat-and-raise. Adj EPS $4.69 vs ~$4.14 expected, revenue $112.7B beat; medical cost ratio better than feared (88.4% vs ~89.9%). Raised full-year profit outlook. Stock up ~3–5% premarket. Management highlighting progress managing elevated medical costs via value-based care and AI.

$JPMorgan Chase(JPM.US): Miss. EPS $5.57 (or ~$5.75 ex items) vs ~$5.90 expected; revenue light. IB fees moderated sequentially (still up YoY); markets solid. Raised NII guidance. Stock softer. Dimon commentary cautious on large fiscal deficits, sticky inflation, elevated asset prices, rising rates, and geopolitics despite resilient consumer/business activity.

$Wells Fargo(WFC.US): Roughly in-line to slight beat on EPS, revenue light; credit metrics solid.

Overall tone is cautious optimism on the consumer and trading, but investors are parsing guidance and credit closely against high yields and geopolitical noise. Options had priced meaningful moves (especially $Unitedhealth(UNH.US) and $JPMorgan Chase(JPM.US)).

Macro & Other

Oil’s decline is the clearest near-term positive for inflation/yields after recent upward pressure tied to Middle East risks (Saudi supply concerns, regional tensions). Michigan preliminary sentiment fell to 46.3; year-ahead inflation expectations ticked to 4.7% (5-year to 3.5%). Fed speakers (including Waller) and existing-home sales data are on the calendar today; CPI tomorrow is the bigger data catalyst.

Selective analyst action includes positive software notes (e.g., $Salesforce(CRM.US) double upgrade at BofA on AI agents/cash flow) offsetting some broader tech caution. Premarket has heavy speculative volume in microcaps (biotech names like $Bio-key(BKYI.US), $Alaunos Therapeutics(TCRT.US) and others gapping hard), but these are lower-quality for multi-day swing setups.

Bottom line for traders: The live narrative is Chinese memory competition challenging the commodity DRAM scarcity premium while HBM/AI demand remains the structural support. Bank results are providing a partial offset via $Goldman Sachs(GS.US) / $Unitedhealth(UNH.US) strength, but the tape is still sensitive to any further AI de-risking or inflation data. Minimize drawdowns by respecting the memory overhang and CPI setup rather than forcing dips into unconfirmed reversals.

NFA / DYOR. Not investment advice.

Minerva Morning Update

10/9/2026

Friday Morning Mish-Mash

No single thread. Thursday was an AI-revenue scare that hit the complex hard — Nasdaq −1.25% to 27,193, S&P −0.47% to 7,765, SOX −3.4% — and Friday’s open is a partial unwind plus two discrete catalysts that actually change positioning: SpaceX buying its way into the carrier stack, and Lumentum saying the optical book is sold out through early 2029. Oil is slipping after Trump pushed any Iran strike past the Nov. 3 midterms. Futures: Nasdaq +0.7–0.8%, S&P +0.4%, Dow flat to +0.1%. Indexes were still on track for slim weekly gains into the print. Banks and CPI next week. Don’t force a thesis.

★ MOST ACTIONABLE · $SpaceX(SPCX.US) $AT & T(T.US) $Verizon(VZ.US) $AT & T(T.US)MUS $American Tower(AMT.US) $Crown Castle(CCI.US) $SBA Communications(SBAC.US)

SpaceX Buys the 800 MHz Book — Starlink Mobile as a Fourth Carrier

SpaceX agreed to buy Grain Management’s nationwide 800 MHz portfolio, about $8 billion cash per the WSJ, subject to FCC approval. Up to 14 MHz of paired low-band. The point of the band is indoor penetration — walls and tree cover — which mid-band 2 GHz direct-to-cell does not do. SpaceX’s line: with this plus the Gen2 constellation (FCC cleared 15,000 V2 satellites this week, company claims >100x current bandwidth), Starlink Mobile becomes a major US carrier, satellite plus terrestrial, not a dead-zone add-on. Musk: “complete phone coverage in America.”

Tape: SPCX +3.7% premarket. TMUS and T −6% to −7.5%, VZ −5.3%. Towers the other side — AMT, CCI, SBAC +7–8%. Grain had only just taken this book off T-Mobile in August for cash plus 600 MHz. Verizon’s response is the bear case in one line: spectrum without a terrestrial network is empty airwaves. Capacity in dense urban cores is the open question; New Street-type framing is that a Starlink broadband + mobile bundle (Grok in the package is the xAI kicker being floated) is the real product, not a like-for-like replacement of macro RAN on day one.

Swing read: this is a narrative shock, not a completed network. Incumbent multiple compression can run for days while the FCC clock and build economics get debated. Towers are the hedge — more nodes if Starlink densifies, or a relative-safety bid if the market decides the moat just cracked. EchoStar (ECHO +4%) is the prior spectrum seller sitting in the same complex.

★ MOST ACTIONABLE · ▲ POSITIVE · $Lumentum(LITE.US) $Coherent Corp.(COHR.US) $Applied Optoelectronics(AAOI.US) $Ciena(CIEN.US)

Optics: Sold Out Through Early 2029

Lumentum CEO Michael Hurlston, Tokyo, Friday: optical components “completely sold out” through early 2029. Cannot meet ~70% of demand for some products through next year; still short ~30% of demand on others through 2028. Six months ago the sell-out date he was using was 2028. “We are very, very far behind what customers want… no end in sight.” Nvidia put $2 billion into LITE and $2 billion into Coherent earlier this year. Street expects Lumentum sales to more than double this year.

Premarket: LITE +6%, COHR +5%, with CIEN / AAOI / GLW bid. This is the reversal of Thursday’s optical dump — COHR −9.6%, GLW −6.4%, LITE −5.6% — which was the OpenAI-revenue contagion, not a demand print. FinTwit will treat Hurlston as the clean rebuttal to the “AI capex air pocket” story. It is a supply comment, not a margin or pricing comment. Chase risk is real after a 180%+ YTD on LITE.

OpenAI: The $50B Scare, Then the $70B Walk-Back

What hit the tape Thursday: FT / Bloomberg — annualized revenue ~$50 billion at end of September, vs. the ~$70 billion figure that had been circulating. Enterprise run-rate +107% in Q3, total +77%, per a person familiar cited by CNBC. Anthropic was already through ~$65 billion annualized at end of July, which is why the comparison stung.

What repaired it overnight: Bloomberg — OpenAI told investors it expects to reach or exceed $70 billion annualized by year-end, enterprise-led. NVDA and AMD +~1.7% premarket, AVGO +2.1%. Roundhill DRAM and SOXX +~2%. Thursday damage: NVDA −2.9%, AMD −3.9%, AVGO −4.4%, MU −4.8%, SNDK −4.9%, ORCL −5.5%, INTC −5.3%.

Expert split worth keeping: Bloomberg Intelligence’s Mandeep Singh — revenue-accounting noise, token growth still says infrastructure demand is intact. The bear camp (and Thursday’s price) says a $20 billion hole versus the number the Street was underwriting is exactly how circular-financing anxiety gets a bid. Both can be true for a few sessions. Memory does not get the same overnight absolution optics just got.

▼ NEGATIVE · $Apple(AAPL.US)

Apple Cuts iPhone 18 Pro Orders

Nikkei: Apple told suppliers to cut component orders for iPhone 18 Pro and 18 Pro Max. Memory inflation forced price hikes; premium uptake is softer than the build plan. AAPL −2%+ premarket. This is the other side of the MU / SNDK tape — hyperscaler LTAs win, the handset OEM eats BOM or cuts units. Gross-margin story at the flagship, not a volume story, and the order cut says they are choosing units down over full pass-through.

Offset, not a savior: Bloomberg says a first touchscreen MacBook and a new iPad mini around Oct. 27, plus 14-inch MacBook Pro and iMac on M6, OLED, lighter Pros, Dynamic Island on the Mac. A product event is a headline; it does not fix a Pro-cycle build cut.

★ MOST ACTIONABLE · ▲ $Humana(HUM.US) · ▼ $Alignment Healthcare(ALHC.US)

CMS 2027 Stars — Bonus Money Just Got Allocated

Humana: 95% of Medicare Advantage members in 4.0-star-or-better plans for 2027; 42% in 4.5-star. HUM +15–16% premarket. That is the quality-bonus pool reopening. Alignment Healthcare: a 2027 plan at 3.5 stars, ALHC −20%+. Aetna (CVS): more than 69% of MA members in 4-star-or-better. Clover (CLOV) +10% in sympathy.

Stars are a multi-quarter payment event, not a one-day gap. The trade is the gap versus the bonus math — HUM’s rerating can extend if the 4.5-star cohort is big enough to move 2027 revenue; ALHC is a broken-rating story until management shows a path back to 4.0. Managed care was already a relative hideout while AI de-grossed on Thursday.

▼ NEGATIVE · $Delta Air Lines(DAL.US) · ▲ $Valero Energy Corp New(VLO.US) $Marathon Petroleum(MPC.US)

Delta Misses and Cuts — Fuel Is the P&L

DAL Q3 adj. EPS $1.72 vs. $1.89, revenue $17.59B vs. $17.66B. Full-year adj. EPS cut to $5.10–$5.60 from $6.50–$7.50 in July. Midpoint $5.35 sits under the $5.46 consensus. Annual fuel bill seen ~$6 billion higher than last year. Stock −3%. Demand in the premium cabin is fine; the barrel is not.

Refiners are the long side of the same fact. WSJ this morning: VLO, MPC, PSX set to crush already-strong June-quarter results as wars shrink product supply. Thursday tape already knew — MPC +4.8%, VLO +4.6%. Gulf product exports still estimated around half of pre-war levels. Distillate tightness is the structural piece; the flat price is the tradeable piece.

Macro: Oil Pause, Fed Still Leaning Higher

Trump said the US will not attack Iran before the midterms. WTI ~$90.50 (−1%), Brent ~$103 (−1.4%), off Thursday’s spike (WTI +3.6%, Brent +4.1%, Brent through $104–106 intraday on strike chatter and Hormuz tanker noise). A three-week geopolitical pause is not a supply fix. Hurricane risk still sits on Gulf output.

Fed: policy is 3.75–4.00% after Warsh’s September hike, the first in three years. Musalem Thursday: more firming required, another hike inside six to nine months if you want 2% inside ~18 months. Waller: more hikes likely, but not necessarily consecutive — October pause is open. Minutes: most participants saw another hike by year-end; several say current policy is not restrictive. Futures: October hold the base case (meeting is Oct. 27–28, a week before the election), December still live. 10-year around 5.25%. Today: Michigan sentiment and inflation expectations at 10:00 ET, WASDE at noon, rigs at 1:00 ET.

Analyst Desk

Barclays reshuffled eVTOL overnight: ACHR to Overweight, target $8 from $4.50; EVTL to Equal Weight from Underweight; JOBY to Underweight. A pair trade inside a group the market still treats as a narrative, not a certification calendar.

Morgan Stanley: CBOE to Overweight from Underweight, target $358 from $258 — S&P contract renewal removes the overhang, KPI contracts seen as upside outside the model. GEMI to Underweight, target $4.75 from $5.50 — crypto beta does not fix scale or a path to profitable growth.

JPMorgan: VFC to Neutral from Underweight, target $18 unchanged. KBW cut GNW and VOYA to Market Perform.

Also on the Wire

Samsung is the first tech name to forecast quarterly operating profit above ₩100 trillion (~$74.7 billion). Supportive for the memory-shortage narrative even after US memory was offered on Thursday. Do not confuse a Korean print with a US multiple.

PepsiCo beat on Thursday and was a rare large-cap green print in a red tape. Not a sector call.

RTX: $6.34 billion Standard Missile-3 production award. KOPN: additional $18.6 million US Army contract. Defense bid is idiosyncratic, not a group day.

Canada unemployment 6.5% in September. A small read-through for North American cyclicals, not a US print.

VEEA +40%+ on regained Nasdaq compliance after a reverse split and board cleanup. Micro-cap listing repair, not a signal.

Next week is the real earnings card: big banks Tuesday onward, CPI in the same window. Thursday’s software bounce (CSGP +8%, GDDY and ACN +6%) was a de-grossing of AI beta into “cheap quality,” not a fundamental reset. If the OpenAI walk-back holds through the cash open, that rotation can give some back.

NFA. DYOR. Not investment advice. Catalysts cut both ways; size for the gap, not the headline.

Decent day today but a lot of AI names gave up their gains when the $Workday(WDAY.US) news broke out possibly leading to L/S funds having to cover software shorts vs their semi longs.

Top gainers: $Sandisk(SNDK.US) $SPY $QQQ $Archer Aviation(ACHR.US) $Red Violet(RDVT.US) $CloudFlare(NET.US) $Backblaze(BLZE.US) $First Advantage(FA.US)

📊 Watchlist (not financial advice)

$Sitime(SITM.US) $Paycom Software(PAYC.US) $Aeva Tech(AEVA.US) $Caris Life Sciences(CAI.US) $Remitly Global(RELY.US) $NN(NNBR.US) $Clover Health Investments(CLOV.US) $Magnite(MGNI.US) $Intapp(INTA.US) $Motorola Solution(MSI.US)

📌 See pinned tweet for how I use my WL

Broad strength today and non-stop rally!

Top gainers for me: $QQQ $SPY $Corning(GLW.US) $Sandisk(SNDK.US) $Bel Fuse-B(BELFB.US) $Amkor Tech(AMKR.US) $NetApp(NTAP.US) $Marvell Tech(MRVL.US) $Brady(BRC.US)

The Fintwit ban on P/L screenshots is hereby lifted :)

$SPY $Alphabet(GOOGL.US) $Forum Energy Tech(FET.US) $QQQ $Porch(PRCH.US) $Corning(GLW.US) $Sandisk(SNDK.US) $Impinj(PI.US)

📊 Watchlist for tomorrow (Not Financial Advice)

$Celestica(CLS.US) $Cadence Design(CDNS.US) $Enova(ENVA.US) $SAP AG-Sponsored(SAP.US) $ServiceNow(NOW.US) $AAR(AIR.US) $FirstCash(FCFS.US) $Goosehead Insurance(GSHD.US) $General Motors(GM.US) $Precigen(PGEN.US)

📌 See pinned tweet for how I use my WL

📊 Watchlist for tomorrow (Not Financial Advice)

$GE Vernova(GEV.US) $Frontline(FRO.US) $Medpace(MEDP.US) $Affiliated Managers(AMG.US) $MSCI(MSCI.US) $Cintas(CTAS.US) $Range Resources(RRC.US) $Yeti(YETI.US) $State Street(STT.US) $Alphabet(GOOGL.US)

📌 See pinned tweet for how I use my WL